US 7084239
Cancer peptides of NY-ESO-1/CAG-3
granted A61KA61K38/00
Quick answer
US patent 7084239 (Cancer peptides of NY-ESO-1/CAG-3) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 41
- CPC classes
- A61K, A61K38/00